- Home
- SAVA vs OSUR Comparison
SAVA vs OSUR Comparison
Compare SAVA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- OSUR
- Stock Information
- Founded
- SAVA 1998
- OSUR 2000
- Country
- SAVA United States
- OSUR United States
- Employees
- SAVA N/A
- OSUR N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- SAVA Health Care
- OSUR Health Care
- Exchange
- SAVA Nasdaq
- OSUR Nasdaq
- Market Cap
- SAVA 213.0M
- OSUR 231.1M
- IPO Year
- SAVA N/A
- OSUR 1986
- Fundamental
- Price
- SAVA $3.82
- OSUR $2.95
- Analyst Decision
- SAVA Buy
- OSUR Hold
- Analyst Count
- SAVA 2
- OSUR 1
- Target Price
- SAVA $5.00
- OSUR $3.00
- AVG Volume (30 Days)
- SAVA 3.1M
- OSUR 464.3K
- Earning Date
- SAVA 11-07-2025
- OSUR 11-10-2025
- Dividend Yield
- SAVA N/A
- OSUR N/A
- EPS Growth
- SAVA N/A
- OSUR N/A
- EPS
- SAVA N/A
- OSUR N/A
- Revenue
- SAVA N/A
- OSUR $138,533,000.00
- Revenue This Year
- SAVA N/A
- OSUR N/A
- Revenue Next Year
- SAVA N/A
- OSUR $4.32
- P/E Ratio
- SAVA N/A
- OSUR N/A
- Revenue Growth
- SAVA N/A
- OSUR N/A
- 52 Week Low
- SAVA $1.15
- OSUR $2.36
- 52 Week High
- SAVA $33.98
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- SAVA 53.58
- OSUR 41.61
- Support Level
- SAVA $3.62
- OSUR $2.86
- Resistance Level
- SAVA $4.69
- OSUR $3.14
- Average True Range (ATR)
- SAVA 0.39
- OSUR 0.11
- MACD
- SAVA -0.08
- OSUR -0.02
- Stochastic Oscillator
- SAVA 26.42
- OSUR 19.62
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.